RenovoRx, Inc. (RNXT): Price and Financial Metrics
RNXT Price/Volume Stats
| Current price | $1.25 | 52-week high | $2.35 |
| Prev. close | $1.15 | 52-week low | $0.71 |
| Day low | $1.14 | Volume | 94,800 |
| Day high | $1.27 | Avg. volume | 50,617 |
| 50-day MA | $1.14 | Dividend yield | N/A |
| 200-day MA | $1.18 | Market Cap | 30.00M |
RNXT Stock Price Chart Interactive Chart >
RenovoRx, Inc. (RNXT) Company Bio
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company was founded in 2009 and is headquartered in Los Altos, California.
RNXT Price Returns
| 1-mo | 3.30% |
| 3-mo | 2.46% |
| 6-mo | 9.17% |
| 1-year | 21.36% |
| 3-year | -74.59% |
| 5-year | N/A |
| YTD | -45.41% |
| 2023 | -2.55% |
| 2022 | -51.45% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...